LEVERAGE LONG - ALMIRALL Share Price

Certificat

Z1003

DE000SN2BPG1

Delayed BME 16:30:00 25/06/2024 BST
0.3 EUR 0.00% Intraday chart for LEVERAGE LONG - ALMIRALL
Current year-28.57%
Date Price Change
25/06/24 0.3 0.00%
24/06/24 0.3 0.00%
21/06/24 0.3 0.00%
20/06/24 0.3 0.00%
19/06/24 0.3 0.00%

Delayed Quote BME

Last update June 25, 2024 at 04:30 pm

More quotes

Static data

Product typeProduits Exotiques
Buy / SellCALL
Underlying ALMIRALL, S.A.
IssuerLogo Issuer Société Générale Société Générale
Z1003
ISINDE000SN2BPG1
Date issued 27/05/2021
Maturity Unlimited
Parity 1 : 1
Emission price 5.13
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 5.75
Lowest since issue 0.27

Company Profile

Almirall SA is a Spain-based company principally engaged in the pharmaceuticals manufacture. The Company focuses on development and marketing of drugs applied in various therapeutic areas, such as nervous system, gastrointestinal, dermatological, respiratory system, antiinfectives, as well as antineoplastic and immunomodulating agents. The Company's activities are divided into four business segments: Own network, which focuses on the commercialization of pharmaceuticals through own brand names; Licenses, which sells product rights to third parties; Research and development (R&D), which is responsible for the creation of drug candidates, as well as Dermatology, which includes sale of dermatological medicines in the United States. The Company operates through numerous subsidiaries in Europe, the Americas, Africa, Asia and Australia.
Sector
-
More about the company

Ratings for Almirall, S.A.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Almirall, S.A.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
9.55 EUR
Average target price
11.46 EUR
Spread / Average Target
+20.04%
Consensus
  1. Stock Market
  2. Certificates
  3. Z1003 Certificat